Trending News: Single Dose HPV Vaccine May be Effective in Cervical Cancer Prevention
Top news from across the health care landscape.
Patients with Parkinson disease and related disorders (PDRD) who received palliative care (PC) exhibited improved quality of life (QoL) and better symptom burden at 6 months after intervention compared with standard care, according to The American Journal of Managed Care. The study authors evaluated 210 patients with PDRD enrolled at 3 academic tertiary care centers between November 1, 2015, and September 30, 2017, for 1 year, along with 175 caregivers. Primary outcomes of the study included differences in patient QoL and caregiver burden between the PC intervention and standard care groups at 6 months.
Statins and metformin could help to prevent death in patients with high-risk prostate cancer, according to HCP Live. Preliminary research from Thomas Jefferson University including more than 12,000 patients indicates use of statins in combination with metformin could lead to a 32% reduction in all-cause mortality and a 54% reduction in prostate cancer death in patients with high-risk prostate cancer. Specific statins examined in the analysis included pravastatin, rosuvastatin, atorvastatin, fluvastatin, lovastatin, and simvastatin.
The team behind a new retrospective study has provided more evidence that a single human papillomavirus (HPV) vaccine dose may be effective in preventing cervical cancer, according to Contagion Live. In female patients aged 15 and 19 years, HPV vaccination with any number of doses was associated with a lower risk of preinvasive cervical disease. The study authors noted that efforts should focus on not only the need to initiate the HPV vaccine but also the need for beginning and continuing cervical cancer screening among young women who are vaccinated at older ages.